L. Jane McNeilageUriwan YoungchaiyudSenga WhittinghamClinical Research Unit Royal Melbourne HospitalMahidol University2018-06-142018-06-141989-01-01Arthritis &amp; Rheumatism. Vol.32, No.1 (1989), 54-6015290131000435912-s2.0-0024543041https://repository.li.mahidol.ac.th/handle/20.500.14594/15777The profile of antinuclear antibodies (ANA) in 49 Thais with scleroderma (systemic sclerosis) was compared with that in 68 white Australians with scleroderma. Forty‐eight (98%) of the Thais and all (100%) of the white Australians were positive for ANA, with the majority (100% and 97%, respectively) showing a diffuse speckled pattern of nuclear fluorescence. The distribution of the patterns was different in the 2 races; 35 (71%) of the Thais and 17 (25%) of the Australians showed staining of the nucleolus, and 1 (2%) of the Thais and 35 (51%) of the Australians showed staining of the centromeres. The frequency of precipitating antibodies to extractable nuclear antigens was also strikingly different: 86% in Thais and 26% in Australians (P < 0.001). Precipitating antibodies to Scl‐70 (topoisomerase I), the predominant extractable nuclear antigen in patients with scleroderma, were detected in 37 (76%) of the Thais and 18 (26%) of the Australians, and these were shown by Western blotting to react with the Scl‐70 (topoisomerase I)–associated polypeptides. Differences in the frequencies of the ANA specificities in the 2 races were consistent with differences in the clinical manifestations of scleroderma; all of the Thai patients, in contrast to 15% of the Australian patients, had diffuse scleroderma with widespread skin involvement. This suggests that environmental or genetic factors may influence the expression of scleroderma. Copyright © 1989 American College of RheumatologyMahidol UniversityImmunology and MicrobiologyMedicineArticleSCOPUS10.1002/anr.1780320109